Rosenblum Silverman Sutton’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
KA
CS
Rosenblum Silverman Sutton's TDOC Position: Q1 2022 in Review
Rosenblum Silverman Sutton sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 67,426 shares — an estimated $6.19M sold.
Rosenblum Silverman Sutton first reported a position in TDOC in Q2 2016 and held it in 23 quarters. The position peaked at $14.9M in Q3 2020. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.
- Rosenblum Silverman Sutton reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
- Rosenblum Silverman Sutton sold 67,426 Teladoc Health shares in Q1 2022, an estimated $6.19M.
- Rosenblum Silverman Sutton first reported a position in Teladoc Health in Q2 2016 and held it in 23 quarters.
- Rosenblum Silverman Sutton's Teladoc Health position peaked at $14.9M in Q3 2020.
- 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.
Based on Rosenblum Silverman Sutton's 13F filing for Q1 2022, filed 13 May 2022.